Unjha Formulations Q2 Results
- BSE: 531762
- NSE: -
- ISIN: INE576D01015
- Sector: Biotechnology & Drugs
BSE
22.95
-0.11 (-0.48%)
-0.11 (-0.48%)Volume1.19 K
Updated: Fri 6 Feb, 2026 | 15:25:07
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Unjha Formulations Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 3.53 | 3.24 | 8.82% | 3.91 | -9.87% |
| Depreciation/ Amortization | 0.03 | 0.03 | -0.70% | 0.02 | 26.22% |
| Operating Income | 0.76 | 0.37 | 103.63% | -0.13 | 0.00% |
| Net Income | 0.82 | 0.39 | 109.75% | -0.11 | 0.00% |
| Other Operating Expenses Total | 0.57 | 0.38 | 46.87% | 0.37 | 52.58% |
| Net Income Before Taxes | 0.82 | 0.39 | 109.75% | -0.11 | 0.00% |
| Total Revenue | 4.29 | 3.61 | 18.57% | 3.78 | 13.31% |
| Selling/ General/ Admin Expenses Total | 0.15 | 0.13 | 9.12% | 0.12 | 18.72% |
| Diluted Normalized EPS | 1.83 | 0.90 | 103.33% | -0.25 | 0.00% |